EMEA-000332-PIP01-08-M14

Key facts

Invented name
  • Briviact (in Italy: Nubriveo)
  • QG01AA01
Active substance
Brivaracetam
Therapeutic area
Neurology
Decision number
P/0297/2019
PIP number
EMEA-000332-PIP01-08-M14
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral solution
  • Solution for injection
Condition(s) / indication(s)
  • Treatment of epilepsy with partial-onset seizures
  • Treatment of neonatal seizures
Route(s) of administration
  • Oral use
  • Intravenous use
Contact for public enquiries
UCB Pharma S.A.

Tel.  + 353 14632371
E-mail: UCBCares.IE@ucb.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating